{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-025784","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2021-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.477247+00:00","generated_at":"2026-06-28T19:56:39.108588+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bone Biologics closes $7.9M public offering, uplists to Nasdaq Capital Market","bullets":["Completed public offering of 1,510,455 units at $5.25/unit for gross proceeds of $7.9M.","Each unit consists of one share of common stock and one warrant (exercise $6.30, 5-year term).","Warrants are immediately exercisable; underwriter has 45-day option for up to 226,568 additional shares/warrants.","Company effectuated a 1-for-2.5 reverse stock split effective Oct 12, 2021.","Shares and warrants began trading on Nasdaq Capital Market on Oct 13, 2021 under BBLG and BBLGW."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-025784","json":"https://secwatch.observer/filing/0001493152-21-025784.json","markdown":"https://secwatch.observer/filing/0001493152-21-025784.md","text":"https://secwatch.observer/filing/0001493152-21-025784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025784/0001493152-21-025784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025784/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T19:56:39.108588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}